Cardiovascular preventive drugs (nonsteroidal antiinflammatory drugs, aspirin, inhibitors of platelet aggregation, anticoagulants) are among the most frequently used medicines all over the world. Gastrointestinal (GI) complications (hemorrhage, ulceration, perphoration) are among the most frequent side effects of these drugs, however, differences in their pharmacodynamics properties and other pleiotropic effects may substantially modify these unwanted events. Authors, based on international and Hungarian guidelines, summarize the most important data for GI protection, focusing on the use of H-2 receptor blockers and proton pump inhibitors.
|Translated title of the contribution||Protection of gastrointestinal system in cardiovascular diseases|
|Number of pages||10|
|Journal||Lege Artis Medicinae|
|Publication status||Published - Jan 1 2015|
ASJC Scopus subject areas